The collaboration will leverage Abalone Bio’s Functional Antibody Selection Technology platform for an undisclosed ...

One day, probably in the next year or two, a company will claim it has put the first artificial-intelligence-designed ...

First-ever fentanyl overdose prevention vaccine could save thousands of lives annually, with human trials beginning early ...

Dec 2 (Reuters) - The U.S. Food and Drug Administration on Tuesday issued new draft guidance on reducing the use of lab monkeys in preclinical toxicity studies for certain monoclonal antibodies. The ...

SOUTH SAN FRANCISCO, Calif., January 12, 2026--insitro, the AI therapeutics company built on causal biology, today announced the acquisition of CombinAbleAI and the launch of insitro’s TherML™ ...

Explore the transformative potential of bispecific antibodies in multiple myeloma, offering hope for improved patient ...

FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...

Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...

A new multi-pronged antibody design could help immune cells receive stronger activation signals against cancer. Researchers ...

Researchers at the University of Southampton have developed a promising new way to bolster the body's immune system response to cancer.

As we head into the 2026, let's take a look at biotech licensing deals and M&As that were inked in December 2025.